当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 现金流量表

同和药业

(300636)

  

流通市值:25.86亿  总市值:29.56亿
流通股本:3.67亿   总股本:4.20亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金339,151,129.55163,052,924.02749,491,411.77543,433,426.58
  收到的税费返还39,436,480.7623,407,529.653,679,946.9943,912,759.6
  收到其他与经营活动有关的现金25,242,995.447,824,213.9326,966,162.5120,499,825.69
  经营活动现金流入小计403,830,605.75194,284,667.55830,137,521.27607,846,011.87
  购买商品、接受劳务支付的现金176,557,186.0597,708,069.04414,309,194.97249,430,115.46
  支付给职工以及为职工支付的现金102,985,902.7656,772,888.48177,700,710.71132,058,780.22
  支付的各项税费3,513,272.121,264,573.457,130,309.235,801,175.47
  支付其他与经营活动有关的现金29,652,568.916,076,481.6828,926,568.8527,374,325.58
  经营活动现金流出小计312,708,929.83171,822,012.65628,066,783.76414,664,396.73
  经营活动产生的现金流量净额91,121,675.9222,462,654.9202,070,737.51193,181,615.14
二、投资活动产生的现金流量:
  收回投资收到的现金454,192,290.36164,103,194.45599,278,710.77466,708,181.12
  取得投资收益收到的现金376,560.55107,243.84367,655.14144,159.55
  处置固定资产、无形资产和其他长期资产收回的现金净额304,108.2667,081.06391,656.81365,027.45
  投资活动现金流入小计454,872,959.17164,277,519.35600,038,022.72467,217,368.12
  购建固定资产、无形资产和其他长期资产支付的现金99,618,131.5258,450,699.09291,242,885.75282,238,078.23
  投资支付的现金311,014,003.1239,747,123.3325,703,888.9153,337,916.67
  投资活动现金流出小计410,632,134.62298,197,822.39616,946,774.65435,575,994.9
  投资活动产生的现金流量净额44,240,824.55-133,920,303.04-16,908,751.9331,641,373.22
三、筹资活动产生的现金流量:
  取得借款收到的现金122,997,05359,712,000459,890,512.13348,014,762.13
  收到其他与筹资活动有关的现金--10,000,00010,000,000
  筹资活动现金流入小计122,997,05359,712,000469,890,512.13358,014,762.13
  偿还债务支付的现金306,223,059.1383,847,309.13525,620,000467,120,000
  分配股利、利润或偿付利息支付的现金21,867,837.532,631,324.7828,778,546.9925,823,508.81
  支付其他与筹资活动有关的现金463,854.5185,541.813,456,481.114,173,575.6
  筹资活动现金流出小计328,554,751.1686,664,175.71567,855,028.09507,117,084.41
  筹资活动产生的现金流量净额-205,557,698.16-26,952,175.71-97,964,515.96-149,102,322.28
四、汇率变动对现金及现金等价物的影响-6,535,543.07-4,187,012.02233,576.11,405,439.24
五、现金及现金等价物净增加额-76,730,740.76-142,596,835.8787,431,045.7277,126,105.32
  加:期初现金及现金等价物余额252,843,283.48252,843,283.48165,412,237.76165,412,237.76
  期末现金及现金等价物余额176,112,542.72110,246,447.61252,843,283.48242,538,343.08
补充资料:
  净利润24,570,982.63-73,091,433.31-
  资产减值准备12,549,396.58-63,655,296.94-
  固定资产和投资性房地产折旧71,044,031.63-129,453,490-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧71,044,031.63-129,453,490-
  无形资产摊销386,310.73-866,186.24-
  长期待摊费用摊销--509,569.02-
  处置固定资产、无形资产和其他长期资产的损失63,554.06-767,628.83-
  公允价值变动损失---214,316.67-
  财务费用13,745,050.22-12,413,025.03-
  投资损失-162,777.21-1,116,706.88-
  递延所得税-4,010,303.99-2,259,244.38-
  其中:递延所得税资产减少-5,678,187.53-11,079,513.84-
    递延所得税负债增加1,667,883.54--8,820,269.46-
  存货的减少-53,258,772.61--20,125,235.98-
  经营性应收项目的减少-29,333,360.9--37,197,879.57-
  经营性应付项目的增加54,534,359.97-31,454,595.14-
  其他568,770.81--56,827,874.04-
  现金的期末余额176,112,542.72-252,843,283.48-
  减:现金的期初余额252,843,283.48-165,412,237.76-
  现金及现金等价物的净增加额-76,730,740.76-87,431,045.72-
公告日期2026-08-262026-04-292026-04-292025-10-25
审计意见(境内)标准无保留意见
TOP↑